| Days abstinent | Drugs composite | Alcohol composite | BPAQ | SRASBM | Treatment satisfaction |
---|---|---|---|---|---|---|
Help for ASPD | 1.216 (0.161–2.271) | 0.004 (-0.006–0.015) | −0.001 (-0.017–0.014) | 0.103 (0.012–0.194) | 0.024 (-0.014–0.062) | 0.077 (0.016–0.140) |
Baseline value | 0.383 (0.245–0.522) | 0.204 (0.082–0.325) | 0.485 (0.398–0.571) | 0.582 (0.481–0.684) | 0.341 (0.255–0.423) | 0.692 (0.522–0.862) |
Substitution | −5.969 (-9.486–-2.453) | 0.109 (0.075–0.143) | 0.012 (-0.031–0.055) | 0.226 (-0.035–0.487) | 0.082 (-0.040–0.205) | −0.150 (-0.382–0.083) |
Female gender | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
Male gender | 0.135 (-4.211–4.481) | 0.012 (-0.028–0.519) | 0.009 (-0.045–0.064) | −0.207 (-0.541–0.128) | −0.149 (-0.008–0.005) | 0.034 (-0.251–0.319) |
Age | 0.233 (0.048–0.418) | −0.000 (-0.002–0.002) | 0.001 (-0.001–0.003) | −0.003 (-0.017–0.011) | −0.001 (-0.008–0.005) | −0.000 (-0.012–0.012) |
3-month follow-up | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
9-month follow-up | 2.328 (0.307–4.349) | −0.038 (-0.058–-0.017) | 0.000 (-0.032–0.032) | −0.346 (-0.531–0.161) | −0.095 (-0.166–-0.023) | −0.055 (-0.168–0.058) |
15-month follow-up | 1.970 (-0.150–4.089) | −0.044 (-0.066–-0.023) | −0.024 (-0.057–0.009) | −0.433 (-0.627–-0.238) | −0.130 (-0.206–-0.054) | −0.072 (-0.190–0.047) |
Intraclass correlation | ||||||
 Site | .000 | .000 | .000 | .000 | .000 | .000 |
 Patient | .509 (.404–.612) | .043 (.321–.551 | .307 (0.198–0.442) | .360 (.252–.484) | .502 (.377.–.626) | .630 (.534–.718) |